دورية أكاديمية
Primary sclerosing cholangitis and other risk factors for post-transplant lymphoproliferative disease after liver transplantation in adults.
| العنوان: | Primary sclerosing cholangitis and other risk factors for post-transplant lymphoproliferative disease after liver transplantation in adults. |
|---|---|
| المؤلفون: | Ruijter BN; Department of Gastroenterology and Hepatology, LUMC Transplantation Center, Leiden University Medical Center, Leiden, The Netherlands., Tushuizen ME; Department of Gastroenterology and Hepatology, LUMC Transplantation Center, Leiden University Medical Center, Leiden, The Netherlands., van der Helm D; Department of Gastroenterology and Hepatology, LUMC Transplantation Center, Leiden University Medical Center, Leiden, The Netherlands.; Department of Surgery, LUMC Transplantation Center, Leiden University Medical Center, Leiden, The Netherlands., Hew M; Department of Gastroenterology and Hepatology, LUMC Transplantation Center, Leiden University Medical Center, Leiden, The Netherlands., Reeven M; Department of Surgery, Division of HPB and Transplant Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Vossen ACTM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Metselaar HJ; Department of Gastroenterology and Hepatology, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Alwayn IPJ; Department of Surgery, LUMC Transplantation Center, Leiden University Medical Center, Leiden, The Netherlands., Dubbeld J; Department of Surgery, LUMC Transplantation Center, Leiden University Medical Center, Leiden, The Netherlands., Polak WG; Department of Surgery, Division of HPB and Transplant Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Hoek B; Department of Gastroenterology and Hepatology, LUMC Transplantation Center, Leiden University Medical Center, Leiden, The Netherlands. |
| المصدر: | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society [Liver Transpl] 2024 Jun 01; Vol. 30 (6), pp. 640-646. Date of Electronic Publication: 2023 Sep 13. |
| نوع المنشور: | Journal Article; Multicenter Study |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 100909185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-6473 (Electronic) Linking ISSN: 15276465 NLM ISO Abbreviation: Liver Transpl Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2023- : [Philadelphia] : Wolters Kluwer Health, Inc. Original Publication: Philadelphia, PA : W.B. Saunders Co., c2000- |
| مواضيع طبية MeSH: | Liver Transplantation*/adverse effects , Cholangitis, Sclerosing*/surgery , Cholangitis, Sclerosing*/epidemiology , Lymphoproliferative Disorders*/etiology , Lymphoproliferative Disorders*/epidemiology , Postoperative Complications*/epidemiology , Postoperative Complications*/etiology , Epstein-Barr Virus Infections*/epidemiology , Epstein-Barr Virus Infections*/complications , Epstein-Barr Virus Infections*/immunology , Epstein-Barr Virus Infections*/virology, Humans ; Male ; Risk Factors ; Female ; Middle Aged ; Netherlands/epidemiology ; Adult ; Retrospective Studies ; Herpesvirus 4, Human/isolation & purification ; Herpesvirus 4, Human/immunology ; Immunosuppressive Agents/adverse effects ; Aged ; Follow-Up Studies ; Incidence ; Viral Load ; End Stage Liver Disease/surgery ; End Stage Liver Disease/mortality ; End Stage Liver Disease/diagnosis ; Immunosuppression Therapy/adverse effects |
| مستخلص: | Post-transplant lymphoproliferative disease (PTLD) is a rare but serious complication of liver transplantation (LT) with morbidity and mortality. The risk factors for PTLD in adults are ill-defined. This study aimed to assess the risk factors for PTLD after LT in adults. All adult LT recipients between 1986 and 2016 from 2 centers in the Netherlands were included, with follow-up until 2020. PTLD was diagnosed according to the World Health Organization (WHO) classification. Potential risk factors for PTLD were assessed using multivariate Cox regression analysis. A total of 1281 patients were included, of whom 29 (2.3%) developed PTLD. Results show that independent risk factors for PTLD after LT in adults were no Epstein-Barr virus load monitoring strategy, primary sclerosing cholangitis as an indication for LT, era (historic era linked to more intense long-term immunosuppression), and Epstein-Barr virus-seronegative recipient. No other independent risk factors were identified in this study. Of the 207 patients with primary sclerosing cholangitis as an indication for LT, 13 (6.3%) developed PTLD versus 16 out of 1074 (1.5%) patients with other underlying liver diseases (log-rank p <0.001). The yearly PTLD incidence was higher in the first year than in the later years after LT (2.4%/y vs. 0.6%/y) for primary sclerosing cholangitis, but not for other indications (0.16%/y). In Epstein-Barr virus-seronegative recipients PTLD occurred earlier after LT, while in 97% of seropositive recipients it could occur very late after LT. (Copyright © 2023 American Association for the Study of Liver Diseases.) |
| References: | Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378:549–62. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: A major cause of late death. Liver Transpl. 2001;7(11 Suppl 1):S109–18. Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, et al. Posttransplant lymphoproliferative disorders in liver transplantation: A 20-year experience. Ann Surg. 2002;236:429–37. Ruijter BN, Wolterbeek R, Hew M, van Reeven M, van der Helm D, Dubbeld J, et al. Epstein-Barr viral load monitoring strategy and the risk for posttransplant lymphoproliferative disease in adult liver transplantation: A cohort study. Ann Intern Med. 2023;176:174–81. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90. Opelz G, Döhler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant. 2004;4:222–30. Nijland ML, Kersten MJ, Pals ST, Bemelman FJ, ten Berge IJM. Epstein-Barr virus-positive posttransplant lymphoproliferative disease after solid organ transplantation: Pathogenesis, clinical manifestations, diagnosis, and management. Transplantation Direct. 2016;2:e48. Zimmermann T, Hoppe-Lotichius M, Tripkovic V, Barreiros AP, Wehler TC, Zimmermann A, et al. Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD). Eur J Intern Med. 2010;21:208–15. Abu-Shanab A, Ged Y, Ullah N, Houlihan D, McCormick A. Increased incidence of post-transplant lymphoproliferative disorder in autoimmune liver disease: An Irish national experience. J Clin Exp Hepatol. 2018;8:42–9. Mouchli MA, Singh S, Loftus EV Jr, Boardman L, Talwalkar J, Rosen CB, et al. Risk factors and outcomes of de novo cancers (excluding nonmelanoma skin cancer) after liver transplantation for primary sclerosing cholangitis. Transplantation. 2017;101:1859–66. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Sanchez W, Gores GJ. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology. 2009;137:2010–7. Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C. Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: A systematic review of population-based studies. Clin Gastroenterol Hepatol. 2022;20:1687–700.e4. Steenstraten IC, Sebib Korkmaz K, Trivedi PJ, Inderson A, van Hoek B, Rodriguez Girondo MDM, et al. Systematic review with meta-analysis: Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. Aliment Pharmacol Ther. 2019;49:636–43. Visseren T, Erler NS, Heimbach JK, Eaton JE, Selzner N, Gulamhusein A, et al. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicenter study. JHEP Rep. 2022;4:100599. Liaskou E, Quraishi NM, Trivedi PJ. Mucosal immunity in primary sclerosing cholangitis: From the bowel to bile ducts and back again. Curr Opin Gastroenterol. 2022;38:104–13. Mammadov RA, Selten JW, Roest HP, Verhoeven CJ, Maroni L, Bril SI, et al. Intestinal bacteriemia after liver transplantationis a risk factor for recurrence of primary sclerosing cholangitis. Transplantation. 2023;107:1764–75. |
| تواريخ الأحداث: | Date Created: 20230912 Date Completed: 20240516 Latest Revision: 20240717 |
| رمز التحديث: | 20240717 |
| DOI: | 10.1097/LVT.0000000000000256 |
| PMID: | 37698933 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1527-6473 |
|---|---|
| DOI: | 10.1097/LVT.0000000000000256 |